Company
Glucotrack, Inc. (GCTK)
Standardized SEC financial data for Glucotrack, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001506983 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Revenue growth (YoY)
378.3%
Return on equity
-685.6%
Free cash flow
-$15.3M
Current ratio
1.61×
EPS (diluted)
$31.22
Ratios for fiscal year 2019, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $1.5M | $1.8M | $2.0M | $4.7M | $9.5M | $9.8M |
| SG&A expense |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.1M | $2.3M | — | $4.5M | $5.6M | $7.4M |
| Inventory |
Get GCTK data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/GCTK/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/GCTK/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"